{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:21:04Z","timestamp":1767864064331,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ygyno.2007.08.074","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T11:30:49Z","timestamp":1191324649000},"page":"554-562","source":"Crossref","is-referenced-by-count":42,"title":["Phase I\/II clinical safety studies of terameprocol vaginal ointment"],"prefix":"10.1016","volume":"107","author":[{"given":"Niharika","family":"Khanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Dalby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.08.074_bib1","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1073\/pnas.92.24.11239","article-title":"Inhibition of human immunodeficiency virus type I transcription and replication by DNA sequence-selective lignans","volume":"92","author":"Gnabre","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10.1016\/j.ygyno.2007.08.074_bib2","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/jm970819w","article-title":"Antiviral activity of methylated nordihydroguaiaretic acid (I) synthesis, structural identification and inhibition of Tat regulated HIV transactivation","volume":"41","author":"Hwu","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.ygyno.2007.08.074_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jmb.2005.04.001","article-title":"Influence of ions hydration and the transcriptional inhibitor P4N on conformations of the Sp1 binding site","volume":"349","author":"Dohm","year":"2005","journal-title":"J Mol Biol"},{"issue":"14","key":"10.1016\/j.ygyno.2007.08.074_bib4","first-page":"5499","article-title":"Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo","volume":"61","author":"Heller","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.08.074_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(01)00560-2","article-title":"Tetra-O-methyl nordihydroguaiaretic acid inhibits melanoma in vivo","volume":"171","author":"Lambert","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2007.08.074_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(00)00089-9","article-title":"Inhibition of human papillomavirus 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives","volume":"47","author":"Craigo","year":"2000","journal-title":"Antivir Res"},{"key":"10.1016\/j.ygyno.2007.08.074_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(02)00165-1","article-title":"Inhibition of HSV-1 replication and reactivation by the mutation-insensitive transcription inhibitor tetra-O-glycyl-nordihydro-guaiaretic acid","volume":"58","author":"Park","year":"2003","journal-title":"Antivir Res"},{"issue":"16","key":"10.1016\/j.ygyno.2007.08.074_bib8","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1021\/jm980182w","article-title":"Antiviral activities of methylated nordihydroguaiaretic acid: 2. Targeting HERPES simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA","volume":"41","author":"Chen","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.ygyno.2007.08.074_bib9","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1073\/pnas.0405407101","article-title":"Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting CDC2 and survivin expression","volume":"101","author":"Chang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2007.08.074_bib10","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1158\/1078-0432.CCR-04-2188","article-title":"Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors","volume":"11","author":"Park","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ygyno.2007.08.074_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.seminoncol.2006.04.010","article-title":"Survivin dependent and independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid","volume":"33","author":"Huang","year":"2006","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.074_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2007.08.074_bib13","author":"American Cancer Society Cancer Facts and Figures"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.074_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00128360-200307000-00002","article-title":"ASCCP sponsored Consensus Workshop. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia","volume":"7","author":"Wright","year":"2003","journal-title":"J Low Genit Tract Dis"},{"issue":"12","key":"10.1016\/j.ygyno.2007.08.074_bib15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"9446","key":"10.1016\/j.ygyno.2007.08.074_bib16","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2007.08.074_bib17","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0020-7292(07)60005-8","article-title":"Pathology of HPV infection at the cytologic and histologic levels: basis for a 2-tiered morphologic classification system","volume":"94","author":"Wright","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.074_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0090-8258(03)00268-3","article-title":"Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization","volume":"90","author":"Costa","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.08.074_bib19","doi-asserted-by":"crossref","unstructured":"Goel S, Burris H, Mendelson D, Gollamudi R, Stern J, Frazer N, Jones S, Gordon M, Mani S. A Phase I\/II study of intravenous tetra-O-methyl nordihydroguaiaretic acid in patients with refractory malignancy. Journal of Clinical Oncology; 2007 ASCO Annual Meeting Proceedings Part I(Vol 25)No.18S (June 20 Supplement):158s Abstract 3584.","DOI":"10.1200\/jco.2007.25.18_suppl.3584"},{"key":"10.1016\/j.ygyno.2007.08.074_bib20","unstructured":"Common Toxicity Criteria v2.0 (CTC) [online]. [cited 1999 April 30]; Available from: URL:http:\/\/ctep.cancer.gov\/reporting\/ctc.html."},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.074_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-4347(00)00592-2","article-title":"Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse","volume":"754","author":"Lambert","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.ygyno.2007.08.074_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-4899-1959-5_25","article-title":"Accelerator mass spectrometry as a bioanalytical tool for nutritional research","volume":"445","author":"Vogel","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ygyno.2007.08.074_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clpt.2006.05.008","article-title":"Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs","volume":"80","author":"Lappin","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ygyno.2007.08.074_bib24","series-title":"Guidance for industry, investigators and reviewers. Exploratory IND studies. Draft guidance","year":"2005"},{"key":"10.1016\/j.ygyno.2007.08.074_bib25","unstructured":"http:\/\/www.pharmprofiles.co.uk\/UserFiles\/File\/pdf\/ErimosPosterOct06.pdf."},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2007.08.074_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0166-0934(03)00186-1","article-title":"Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays","volume":"112","author":"Gravitt","year":"2003","journal-title":"J Virol Methods"},{"issue":"11","key":"10.1016\/j.ygyno.2007.08.074_bib27","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/JCM.36.11.3248-3254.1998","article-title":"Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies","volume":"36","author":"Peyton","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ygyno.2007.08.074_bib28","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JCM.00049-06","article-title":"Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples","volume":"44","author":"Sandri","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.074_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0928-0197(98)00015-4","article-title":"Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods","volume":"10","author":"Nindl","year":"1998","journal-title":"Clin Diagn Virol"},{"issue":"4","key":"10.1016\/j.ygyno.2007.08.074_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.lgt.0000225889.13916.c6","article-title":"Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections","volume":"10","author":"Smith-McCune","year":"2006","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.074_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.virusres.2006.04.009","article-title":"The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers","volume":"121","author":"Marais","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.ygyno.2007.08.074_bib32","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.92.25.11553","article-title":"Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas","volume":"92","author":"Suzich","year":"1995","journal-title":"Proc Natl Acad Sci"},{"issue":"17","key":"10.1016\/j.ygyno.2007.08.074_bib33","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1001\/jama.291.17.2100","article-title":"Treatment for cervical intraepithelial neoplasia and risk of preterm delivery","volume":"291","author":"Sadler","year":"2004","journal-title":"JAMA"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807006452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807006452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:04:06Z","timestamp":1587945846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807006452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0090825807006452"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.08.074","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}